Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation.
Oberbauer R, Segoloni G, Campistol JM, Kreis H, Mota A, Lawen J, Russ G, Grinyó JM, Stallone G, Hartmann A, Pinto JR, Chapman J, Burke JT, Brault Y, Neylan JF; Rapamune Maintenance Regimen Study Group. Oberbauer R, et al. Among authors: chapman j. Transpl Int. 2005 Jan;18(1):22-8. doi: 10.1111/j.1432-2277.2004.00052.x. Transpl Int. 2005. PMID: 15612979 Free article. Clinical Trial.
Predictors of renal transplant histology at three months.
Kuypers DR, Chapman JR, O'Connell PJ, Allen RD, Nankivell BJ. Kuypers DR, et al. Among authors: chapman jr. Transplantation. 1999 May 15;67(9):1222-30. doi: 10.1097/00007890-199905150-00005. Transplantation. 1999. PMID: 10342313
Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
Oberbauer R, Kreis H, Johnson RW, Mota A, Claesson K, Ruiz JC, Wilczek H, Jamieson N, Henriques AC, Paczek L, Chapman J, Burke JT; Rapamune Maintenance Regimen Study Group. Oberbauer R, et al. Among authors: chapman j. Transplantation. 2003 Jul 27;76(2):364-70. doi: 10.1097/01.TP.0000074360.62032.39. Transplantation. 2003. PMID: 12883194 Clinical Trial.
Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: an insight from MOST, a multinational observational study.
Salvadori M, Rosati A, Bertoni E, Bock A, Chapman J, Dussol B, Fritsche L, Kliem V, Lebranchu Y, Oppenheimer F, Pohanka E, Tufveson G, Soergel M. Salvadori M, et al. Among authors: chapman j. Transplant Proc. 2006 May;38(4):1010-3. doi: 10.1016/j.transproceed.2006.03.060. Transplant Proc. 2006. PMID: 16757247
Use of proliferation signal inhibitors in the management of post-transplant malignancies--clinical guidance.
Campistol JM, Albanell J, Arns W, Boletis I, Dantal J, de Fijter JW, Mortensen SA, Neumayer HH, Øyen O, Pascual J, Pohanka E, Schena FP, Serón D, Sparacino V, Chapman JR. Campistol JM, et al. Among authors: chapman jr. Nephrol Dial Transplant. 2007 May;22 Suppl 1:i36-41. doi: 10.1093/ndt/gfm090. Nephrol Dial Transplant. 2007. PMID: 17456617 Review.
Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function.
Friend P, Russ G, Oberbauer R, Murgia MG, Tufveson G, Chapman J, Blancho G, Mota A, Grandaliano G, Campistol JM, Brault Y, Burke JT; Rapamune Maintenance Regimen (RMR) Study Group. Friend P, et al. Among authors: chapman j. Transpl Int. 2007 Sep;20(9):754-60. doi: 10.1111/j.1432-2277.2007.00506.x. Epub 2007 Jun 12. Transpl Int. 2007. PMID: 17565578 Free article. Clinical Trial.
4,294 results